Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 617.18B, Johnson & Johnson(JNJ) trades at $256.03. The stock has a price-to-earnings ratio of 29.98 and currently yields dividends of 2.04%.
As of 2026-10-02, Johnson & Johnson(JNJ) stock has fluctuated between $255.12 and $260.50. The current price stands at $256.03, placing the stock +0.4% above today's low and -1.7% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 7.89M, compared to an average daily volume of 7.11M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $182.94.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $182.94.
JNJ News
Investing Dave Ramsey Says Single Stocks Are a Gamble. What That Means if You Live on Dividends Dave Ramsey has called single stocks a gamble for years, but ret...
...
Johnson & Johnson (NYSE: JNJ) advanced its gene therapy candidate Botaretigene sparoparvovec for X-linked retinitis pigmentosa in ongoing regulatory and clinica...
Analyst ratings
70%
of 27 ratingsMore JNJ News
Johnson & Johnson announced new two-year data from the Phase 3 ICONIC-TOTAL study demonstrating the positive impact of ICOTYDE on high-impact plaque psoriasis s...
Choosing between the diversified stability of Johnson & Johnson (JNJ -2.30%) and the rapid growth trajectory of Eli Lilly & Co (LLY -0.63%) is a primary conside...
Bristol Myers Squibb: Slow and Steady Revenue Growth Bristol Myers Squibb (BMY -1.23%) operates as a global biopharmaceutical entity that researches, develops,...
Investing JNJ or MRK: One Dividend Is Built to Last, One Faces a Reckoning Both JNJ and MRK have surged in 2026, but a looming patent cliff and a balance sheet...
Johnson & Johnson's (JNJ -1.06%) stock has absolutely crushed Medtronic's (MDT -0.92%) over the last decade. The iconic healthcare giant has generated a nearly...
has been on a strong multi‑year run, and that kind of share price climb naturally raises a question about whether the current valuation still lines up with the...
Bank of America just raised price targets on two pharma giants facing patent cliffs, but its conviction level differs sharply between them, and the valuation ga...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.